Trial Details
RecruitingBasic Information
| Clinical ID | c4967 |
|---|---|
| Identifier | ISRCTN95420128 |
| Trial Title | Subcutaneous CT-P13 monotherapy versus combination with immunomodulation when switching from intravenous infliximab in inflammatory bowel disease A multicentre, randomised withdrawal trial |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Crohn's disease and ulcerative colitis Digestive System |
| Interventions | The intervention is the withdrawal of immunomodulators (azathioprine or mercaptopurine) in IBD patients switching from IV infliximab to subcutaneous infliximab (SC CT-P13). Participants will be randomised 1:1 to either continue or discontinue immunomodul |
Participant Information
| Sponsor | Kings Health Partners |
|---|---|
| City | NULL |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |